
Health
India extends 30% trade-margin cap to 137 more cancer drugs
The medicines-pricing authority analysed the large trade mark-ups cited in the cancer-drug case.
National Pharmaceutical Pricing Authority is a government-run regulatory body in India.

The medicines-pricing authority analysed the large trade mark-ups cited in the cancer-drug case.